EZH2 knockout in PyMT and HER2-driven models demonstrated profound impact on tumor initiation, progression, and metastasis, supporting that EZH2 behaves as on oncogene by suppressing expression of tumor suppressors (Hirukawa et al., 2018; Smith et al., 2019). The gene discussed is EZH2; the disease is neoplasm.